Track sentiment, discussions and live quotes, post ideas and see what real traders are doing

Nebiuss Q3 report is driving attention: traders largely call the results a strong beat, but the stock sold off as investors focused on higher planned capital spending, delayed capacity deliveries and a softer near-term outlook. The debate is whether strong AI-cloud demand and longer-term growth guidance outweigh concerns about execution, funding and the cost of expansion.

Reports that Nvidias board may consider removing CEO Jensen Huang amid allegations involving personal relationships and a suspected Chinese intelligence link have put leadership and security risks in focus, alongside analyst downgrades. Traders are divided between fearing Huangs departure could disrupt Nvidias AI leadership and arguing the controversy is overblown and the companys business remains strong.

Intuitive Machines Q3 results beat expectations, with traders highlighting the record backlog, positive free cash flow and outlook for positive adjusted EBITDA. The reaction is broadly bullish, with some anticipating a short squeeze, while others caution that the earnings-driven rally could fade.

Ondas Q3 earnings and outlook dominate discussion, with traders looking for evidence that rapid growth and defense orders are translating into revenue and progress toward profitability. Bulls point to heavy short interest as potential fuel for a squeeze, while bears emphasize cash burn, dilution and the gap between announced orders and realized sales.

Forgents strong quarterly results and higher full-year guidance are the main focus, with traders also citing robust demand and backlog. Many view the volatile price action as an overreaction, while others point to weak AI-sector sentiment and caution that growth expectations remain a risk.

IonQs quarterly results, higher full-year revenue outlook, and larger backlog are driving attention, with bulls citing stronger commercial momentum and quantum-sector milestones. Skeptics question how much reported growth reflects the SkyWater acquisition and point to cash burn, dilution, and volatile trading.

Capricors rally is centered on the FDAs pending decision on deramiocel for Duchenne muscular dystrophy, with traders weighing managements confidence and the prospect of approval against lingering concerns from the earlier advisory committee review. Bullish posts also speculate about short covering, while others stress that the decision remains a high-risk binary event.

BRUN is drawing attention after Q3 results missed revenue expectations, despite reported growth in contracted business and project financing. Traders are split between frustration over the shortfall and optimism that the backlog and deployment progress can translate into recurring revenue and profitability.

Figures strong Q3 results and upbeat loan-marketplace outlook are drawing attention, with bullish traders calling the report a major beat and pointing to growth in its HELOC and capital-markets platform. That optimism is tempered by debate over the stocks weak trading history and short interest, while squeeze talk remains speculative.

Paysafes earnings and outlook are driving debate: some traders point to revenue growth and reaffirmed guidance, while many focus on continued losses, debt and weak profitability, blaming those concerns for the stocks steep decline. Bulls also cite refinancing and debt reduction as potential positives, but skepticism about managements ability to deliver remains dominant.